A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT03747575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the efficacy and safety of MSTT1041A (astegolimab) in participants with moderate to severe atopic dermatitis (AD). The study consists of a screening period, a 16-week treatment period, and an 8-week follow-up period.
Study identification
- NCT ID
- NCT03747575
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 6, 2019 (Actual)
- Primary completion
- Mar 11, 2020 (Actual)
- Completion
- May 5, 2020 (Actual)
- Last update posted
- May 6, 2023
2019 – 2020
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Allergy & Asthma | Birmingham | Alabama | 35209 | — |
| California Allergy and Asthma Medical Group - CRN | Los Angeles | California | 90025 | — |
| Jonathan Corren MD, Inc. | Los Angeles | California | 90025 | — |
| Asthma & Allergy; Associates, P.C. | Colorado Springs | Colorado | 80907 | — |
| South Coast Research Center, Inc. | Miami | Florida | 33136 | — |
| Harmony Clinical Research, Inc | North Miami Beach | Florida | 33162 | — |
| GCP Global Clinical Professionals | St. Petersburg | Florida | 33702 | — |
| Forward Clinical Trials | Tampa | Florida | 33624 | — |
| Florida Pulmonary Research Institute, LLC | Winter Park | Florida | 32789 | — |
| Midwest Sinus Allergy and Asthma - CRN | Normal | Illinois | 61761 | — |
| Dermatology Specialists Research, LLC | Louisville | Kentucky | 40241 | — |
| Clinical Research Consortium Nevada | Las Vegas | Nevada | 89119 | — |
| Skin Laser and Surgery Specialists of New York and New Jersey LLC - Interspond - PPDS | Hackensack | New Jersey | 07601 | — |
| Vital Prospects Clinical Research Institute PC - CRN | Tulsa | Oklahoma | 74136 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03747575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2023 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03747575 live on ClinicalTrials.gov.